http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#Head http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#provenance http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#pubinfo http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion http://purl.obolibrary.org/obo/MONDO_0005260 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0005260 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB00313 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association http://www.w3.org/2000/01/rdf-schema#label This practice is also observed with increased off-label use of psychotropic drugs includ- ing selective serotonin reuptake inhibitors (SSRIs) [12] for repetitive behaviors, stimulant medications for attention- deficit hyperactivity disorder (ADHD)-type symptoms [25], and anti-epileptic medications such as valproate for behavioral symptoms in ASD [26]. http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/27873285/ http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB00313 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#provenance http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#pubinfo http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig http://purl.org/nanopub/x/hasSignature MfBVm2hugtoQT1cyoowFEmdlUvy8DvrVnO0cdak5XJiDjSAdu5bCHUBr9GKTbre5ATlVJRX7QGkzNZSE+I2tNbPsRDZvgndY+aKnGTHff++tRzibWO6GWyCsihdLJrzW0oQknRqUwBDAKlPh/Gp/sGFIYVgfg4nqnz/LixWvRKo= http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://purl.org/dc/terms/created 2021-05-31T15:21:26.174+02:00 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAPpM47mLRPXvaDW61XZpFrMq0_vIX1h0RfVVN29aoLR8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs